New behavioral program aims to boost resilience in cancer survivors
NCT ID NCT06461416
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This pilot trial tested a behavioral program called ActiveHeal EST in 30 adults recently diagnosed with breast or prostate cancer. The program includes group sessions and home activities to help survivors persist in daily tasks despite challenges. Researchers measured changes in resilience, quality of life, and psychological wellbeing.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ActiveHeal EST Program (behavioral intervention with group and home sessions)
- What this could lead to
- If it works, this program could help cancer survivors maintain daily activities and improve their quality of life.
- What could go wrong
- This is a very small pilot trial with only 30 participants, so results may not apply to everyone. The program is new and needs more testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria * Must be an adult, diagnosed within the last 12 months with prostate or breast cancer and have had treatment(s) that may be ongoing or completed. * Must be 18-75 years old. * Must score 80 to 90 on the Karnofsky Performance Status Scale (KPSS) Exclusion Criteria * Unable to use or lacking access to Teams (internet) and telephone during the study period. * Unable or unwilling to participate in activity-based interventions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Arkansas for Medical Science
Fayetteville, Arkansas, 72203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- A scanner in the operating room could show surgeons exactly where prostate cancer remains
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can daily adaptive radiotherapy spare healthy tissue in prostate cancer?